Explore ViiV Healthcare
Report adverse event
If you are a patient and have experienced an unexpected event when taking one of our medications please speak to your healthcare professional as soon as possible. To lodge a report contact:
Phone: 1800 499 226
DOVATO (dolutegravir/lamivudine) is listed on the Australian Register of Therapeutic Goods (ARTG).
DOVATO is indicated for the treatment of HIV-1 infection in antiretroviral treatment-naïve adults and adolescents (from 12 years of age weighing at least 40 kg) who have no known or suspected resistance to either antiretroviral component.
PBS Information: This product is listed on the PBS as a section 100 item. Refer to PBS schedule for full authority information.